sunny.png
Thursday July 29th, 2021 2:08PM

Pfizer says early data signals COVID-19 vaccine is effective

By The Associated Press
Related Articles
  Contact Editor

Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19, indicating the company is on track later this month to file an emergency use application with U.S. regulators.

Monday's announcement doesn't mean a vaccine is imminent: This interim analysis, from an independent data monitoring board, looked at 94 infections recorded so far in a study that has enrolled nearly 44,000 people in the U.S. and five other countries.

Pfizer Inc. did not provide any more details about those cases, and cautioned the initial protection rate might change by the time the study ends. Even revealing such early data is highly unusual.

“We’re in a position potentially to be able to offer some hope,” Dr. Bill Gruber, Pfizer’s senior vice president of clinical development, told The Associated Press. “We’re very encouraged.”

Authorities have stressed it's unlikely any vaccine will arrive much before the end of the year, and limited initial supplies will be rationed.

“We need to see the data, but this is extremely promising,” said Dr. Jesse Goodman of Georgetown University.

He ticked off many questions still to be answered including how long the vaccine's effects last and if it also protects older people as well as younger people.

If Pfizer's vaccine ultimately pans out, "it’s going to be a while before this has a major impact at the population level,” said Goodman, a former chief of Food and Drug Administration’s vaccine division.

The interim results were “an interesting first signal,” but questions remain, said Marylyn Addo, head of the tropical medicine unit at UKE hospital in Hamburg, Germany.

Global markets, already buoyed by the victory of U.S. President-elect Joe Biden, exploded on the news from Pfizer. All major markets in Europe, where infections have soared, are up 5%. In the U.S., Dow futures also rose 5% and were up about 1,400 points just over two hours before the opening bell.

The shots made by Pfizer and its German partner BioNTech are among 10 possible vaccine candidates in late-stage testing around the world — four of them so far in huge studies in the U.S. Another U.S. company, Moderna Inc., also has said it hopes to be able to file an application with the FDA later this month.

Volunteers in the final-stage studies, and the researchers, don't know who received the real vaccine or a dummy shot. But a week after their second required dose, Pfizer's study began counting the number who developed COVID-19 symptoms and were confirmed to have the coronavirus.

Because the study hasn't ended, Gruber couldn't say how many in each group had infections. Doing the math, that would mean almost all the infections counted so far had to have occurred in people who got the dummy shots.

Pfizer doesn’t plan to stop its study until it records 164 infections among all the volunteers, a number that the FDA has agreed is enough to tell how well the vaccine is working. The agency has made clear that any vaccine must be at least 50% effective.

No participant so far has become severely ill, Gruber said. Nor could he provide a breakdown of how many of the infections had occurred in older people, who are at highest risk from COVID-19.

Participants were tested only if they developed symptoms, leaving unanswered whether vaccinated people could get infected but show no symptoms and unknowingly spread the virus.

FDA has required that U.S. vaccine candidates be studied in at least 30,000 people. In addition to adequate numbers of older adults, those studies must also include other groups at high risk, including minorities and people with chronic health problems.

And it told companies they must track half their participants for side effects for at least two months, the time period when problems typically crop up. Pfizer expects to reach that milestone later this month, but said Monday no serious safety concerns have been reported.

Because the pandemic is still raging, manufacturers hope to seek permission from governments around the world for emergency use of their vaccines while additional testing continues — allowing them to get to market faster than normal but raising concerns about how much scientists will know about the shots.

The FDA's scientific advisers last month said they worry that allowing emergency use of a COVID-19 vaccine could damage confidence in the shots and make it harder to ever find out how well they really work. Those advisers said it's critical these massive studies are allowed to run to completion.

___

AP writers Frank Jordans and Charles Sheehan contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Health, AP Business, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
The Latest: UN health agency vows accountability in pandemic
The World Health Organization’s chief says his agency is committed to “continuous accountability” as an independent panel evaluating WHO’s management of the global response to the coronavirus pandemic gets ready to brief the organization’s countries this week
6:50AM ( 9 minutes ago )
Pfizer says early data signals COVID-19 vaccine is effective
Pfizer says an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19
6:49AM ( 11 minutes ago )
Trump faces calls to work with Biden team on transition
The team helping Joe Biden prepare for the White House and a nonpartisan institution are asking President Donald Trump to cooperate with an orderly transition of power, despite his false claims the election was stolen
6:46AM ( 13 minutes ago )
Associated Press (AP)
The Latest: Portugal enters state of emergency over virus
Portugal has entered a state of emergency, with curfews imposed in the areas worst hit by the COVID-19 pandemic
5:16AM ( 1 hour ago )
The Latest: New Delhi's new virus cases hit record high
India has reported 45,903 new coronavirus cases, with its capital recording the highest single-day rise in infections since the pandemic began
12:54AM ( 6 hours ago )
Pent-up global wish list of hopes, demands awaits Biden
Four years of inward-looking “America First” leadership by outgoing President Donald Trump have generated pent-up global demand for a more engaged and amenable America
11:56PM ( 7 hours ago )
AP Health
Japan's SoftBank back in the black as investments improve
Japanese technology company SoftBank Group Corp. has reported it bounced back to profitability in the last quarter as its investments improved in value
4:45AM ( 2 hours ago )
Asian shares, US futures surge on relief US election decided
Asian shares and U.S. futures are rising on relief the U.S. presidential election results were finally decided, with Joe Biden the president-elect
2:29AM ( 4 hours ago )
Australian media on trial for breaching order in Pell case
High-profile Australian journalists and large media organizations have gone on trial on charges that they breached a gag order on reporting about Cardinal George Pell’s sex abuse convictions in 2018 that have since been overturned
12:56AM ( 6 hours ago )
AP Business
Americans pivot from red-hot Trump to Biden's seasoned cool
Joe Biden's election victory means a pivot in tone for the presidency once he takes office
9:14AM ( 21 hours ago )
Authentic goes wire-to-wire to win Breeders' Cup Classic
Authentic has won the Breeders’ Cup Classic, going wire-to-wire for a 2¼-length victory over Improbable that gave trainer Bob Baffert a 1-2 finish at Keeneland
7:58PM ( 1 day ago )
Monomoy Girl wins Breeders' Cup Distaff at Keeneland
Even-money favorite Monomoy Girl blew by the leaders around the final turn and held off a challenge by 14-1 shot Valiance to win the 1 1/8-mile Distaff for the top fillies and mares 3 years old and up
5:20PM ( 1 day ago )
AP Business - Industries
The Latest: Minnesota hospitals brace for wave of patients
Hospitals and healthcare systems across Minnesota are bracing for a wave of new patients as the state sees alarming growth in virus cases and hospitalizations are expected to follow
7:36PM ( 3 days ago )
AstraZeneca to deliver vaccine trial data by year's end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses starting in January
4:37PM ( 3 days ago )
Greece imposes lockdown to avoid worst at hospitals
With a surge in coronavirus cases straining health systems in many European countries, Greece has announced a nationwide lockdown in the hopes of stemming a rising tide of patients before its hospitals come under “unbearable” pressure
11:58AM ( 3 days ago )
AP Business - Health Care
The Latest: UN health agency vows accountability in pandemic
The World Health Organization’s chief says his agency is committed to “continuous accountability” as an independent panel evaluating WHO’s management of the global response to the coronavirus pandemic gets ready to brief the organization’s countries this week
6:50AM ( 9 minutes ago )
Trump faces calls to work with Biden team on transition
The team helping Joe Biden prepare for the White House and a nonpartisan institution are asking President Donald Trump to cooperate with an orderly transition of power, despite his false claims the election was stolen
6:46AM ( 14 minutes ago )
Turkey's battered currency rises after finance chief resigns
The Turkish lira has firmed against the dollar a day after the country’s finance minister, who is also son-in-law to President Recep Tayyip Erdogan, announced his resignation
6:31AM ( 29 minutes ago )
World markets rise on relief over U.S. election outcome
World markets have reacted with relief that results from the U.S. presidential election were finally decided, with Joe Biden the president-elect
5:44AM ( 1 hour ago )
McCarrick: What's known about the abusive US ex-cardinal
The Vatican is releasing its report into the rise and fall of ex-Cardinal Theodore McCarrick, the once-influential American cardinal who was defrocked by Pope Francis in 2019 after a Vatican investigation confirmed decades of rumors that he was a sexual predator
5:34AM ( 1 hour ago )